HISTOGENICS CORP — Form D

HISTOGENICS CORP of WALTHAM, MA, a company, filed a Form D exempt-offering notice with the SEC on 2016-10-12. The offering totals $30.0M, of which $30.0M was reported sold. Industry: Other Health Care.

Offering

Issuer

Officers, directors & promoters (39)

Showing 25 of 39 people.

NameRoleLocation
Joshua BaltzellDirectorBoston, MA
David J GillDirectorNew Haven, CT
Adam GridleyDirectorLexington, MA
John J JohnsonDirectorWaltham, MA
Garheng Kong, M.D., Ph.D.DirectorWaltham, MA
Michael LewisDirectorBoulder, CO
Jonathan J LieberDirectorHouston, TX
Kevin RakinDirectorNew Haven, CT
Adam GridleyExecutive OfficerLexington, MA
Garheng KongDirectorSeattle, WA
Peter GreenleafDirectorDurham, NC
Peter GreenleafExecutive OfficerDurham, NC
Patrick O'DonnellDirectorPittsburgh, PA
Patrick O'DonnellExecutive OfficerPittsburgh, PA
John JohnsonDirectorChanhassen, MN
Ramesh KumarDirectorCambridge, MA
Kevin McArdleExecutive OfficerBoston, MA
Manish B PottiDirectorMalvern, PA
Sanjay B SubramanianExecutive OfficerMalvern, PA
Suha B TaspolatogluDirectorMalvern, PA
Shankar MusunuriDirectorMalvern, PA
Shankar MusunuriExecutive OfficerMalvern, PA
Daniel B JorgensenExecutive OfficerMalvern, PA
Prabhavathi B FernandesDirectorMalvern, PA
Kristen B CastilloDirectorMalvern, PA

Other filings by this issuer (6)

FiledFormOfferingSold
2020-05-07D$395$395
2020-05-07D$14.3M$14.3M
2014-01-06D$20.6M$10.3M
2012-11-26D/A$58.3M$37.6M
2012-07-27D$58.0M$37.5M
2011-05-26D$34.3M

More